Baseline | Month 1 | Month 3 | Month 6 | Month 12 | |
---|---|---|---|---|---|
Frequency of patients with ≥11 foci(groups C or D) | 58.3% | 40.5% | 45.8% | 22.7% | 21.7% |
Distribution (% patients in each group) | |||||
Group 0 (no foci) | 4.2% | 4.8% | 8.7% | 14.3% | 4.7% |
Group 1 (inner retina) | 45.8% | 47.5% | 56.6% | 57.1% | 66.7% |
Group 2 (outer retina) | 50% | 47.7% | 34.7% | 28.6% | 28.6% |
logMAR VAa | 0.55 (0.4–0.71) | 0.42 (0.25–0.59) | 0.42 (0.18–0.66) | 0.31 (0.19–0.42) | 0.22 (0.08–0.35) |
CMT (μm)b | 453.83 (396.6–511) | 358.34 (301.69–415) | 315.2 (258.4–372.1) | 328.87 (262.3–395.5) | 269.32 (227.7–310.9) |